Antiretroviral Drugs Approved By FDA for HIV
From U.S. Food and Drug Administration
September 21, 1998
A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!
| Brand Name |
Generic Name |
Firm Name |
Approval Date |
| Retrovir Capsules |
zidovudine, AZT |
Glaxo Wellcome |
19 March 87 |
| Retrovir Syrup |
zidovudine, AZT |
Glaxo Wellcome |
28 September 89 |
| Retrovir Injection |
zidovudine, AZT |
Glaxo Wellcome |
02 February 90 |
| Videx |
didanosine, ddI |
Bristol Myers-
Squibb |
09 October 91 |
| Hivid |
zalcitabine,ddC |
Hoffman-La
Roche |
19 June 92 |
| Zerit |
stavudine, d4T |
Bristol Myers-
Squibb |
24 June 94 |
| Epivir |
lamivudine, 3TC |
Glaxo Wellcome |
17 November 95 |
| Invirase |
saquinavir |
Hoffman-La
Roche |
06 December 95 |
| Norvir |
ritonavir |
Abbott
Laboratories |
01 March 96 |
| Crixivan |
indinavir |
Merck & Co., Inc. |
13 March 96 |
| Viramune |
nevirapine |
Boehringer
Ingelheim
Pharmaceuticals,
Inc. |
21 June 96 |
| Viracept |
nelfinavir |
Agouron
Pharmaceuticals |
14 March 97 |
| Rescriptor |
delavirdine |
Pharmacia &
Upjohn |
04 April 97 |
| Combivir |
zidovudine and lamivudine |
Glaxo Wellcome |
26 September 97 |
| Fortovase |
saquinavir |
Hoffman-La
Roche |
07 November 97 |
| Sustiva |
efavirenz |
DuPont Pharmaceuticals |
17 September 98 |
A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!